Serological studies in bullous pemphigoid: a literature review of antibody titers at presentation and in clinical remission
- PMID: 20169293
- DOI: 10.2340/00015555-0819
Serological studies in bullous pemphigoid: a literature review of antibody titers at presentation and in clinical remission
Abstract
Bullous pemphigoid is associated with antibodies to a 230 kDa and a 180 kDa protein. In a literature review we investigated the role of auto-antibodies as detected by different serological assays. Nine reports containing data on 143 patients were analyzed. Pre-treatment data showed that indirect immunofluorescence, enzyme-linked immunosorbent assay (ELISA) and immunoblotting offer an 82.2% or greater probability of being positive. At the end of the study period, all patients had clinically improved, whether or not they were on therapy. Auto-antibodies were present in 29% of patients evaluated by monkey esophagus immunofluorescence and 75% of those evaluated by human skin immunofluorescence. Positive titers were also reported in 67.6% of patients evaluated by ELISA. In 100% of patients in whom immunoblotting was performed the titers became negative. In 3 patients (5.3%) using human skin immunofluorescence and in one patient (1.4%) using ELISA the titers were increased at the end of the study period. The correlation between anti-basement membrane zone antibodies and the clinical course of bullous pemphigoid requires further and long-term studies.
Similar articles
-
Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid.Ann N Y Acad Sci. 2009 Sep;1173:15-20. doi: 10.1111/j.1749-6632.2009.04630.x. Ann N Y Acad Sci. 2009. PMID: 19758126
-
Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.Arch Dermatol. 2011 Mar;147(3):286-91. doi: 10.1001/archdermatol.2011.23. Arch Dermatol. 2011. PMID: 21422334
-
Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.Arch Dermatol. 2011 Mar;147(3):293-8. doi: 10.1001/archdermatol.2011.21. Arch Dermatol. 2011. PMID: 21422336
-
[Bullous pemphigoid: diagnosis and therapy].Wien Med Wochenschr. 2014 Sep;164(17-18):363-71. doi: 10.1007/s10354-014-0294-9. Epub 2014 Jul 31. Wien Med Wochenschr. 2014. PMID: 25077677 Review. German.
-
[Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].Ann Dermatol Venereol. 2013 Aug-Sep;140(8-9):563-70. doi: 10.1016/j.annder.2013.04.082. Epub 2013 May 28. Ann Dermatol Venereol. 2013. PMID: 24034645 Review. French. No abstract available.
Cited by
-
Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid.Indian J Dermatol. 2023 Jan-Feb;68(1):122. doi: 10.4103/ijd.ijd_248_22. Indian J Dermatol. 2023. PMID: 37151247 Free PMC article.
-
Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease.Clin Exp Immunol. 2013 Jan;171(1):76-81. doi: 10.1111/j.1365-2249.2012.04674.x. Clin Exp Immunol. 2013. PMID: 23199326 Free PMC article.
-
Bullous Pemphigoid and Other Pemphigoid Dermatoses.Medicina (Kaunas). 2021 Oct 4;57(10):1061. doi: 10.3390/medicina57101061. Medicina (Kaunas). 2021. PMID: 34684098 Free PMC article. Review.
-
Semaglutide-associated bullous pemphigoid.JAAD Case Rep. 2021 Aug 5;15:107-109. doi: 10.1016/j.jdcr.2021.07.027. eCollection 2021 Sep. JAAD Case Rep. 2021. PMID: 34466645 Free PMC article. No abstract available.
-
Vesiculobullous Diseases.Medicina (Kaunas). 2022 Jan 26;58(2):186. doi: 10.3390/medicina58020186. Medicina (Kaunas). 2022. PMID: 35208511 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical